Cancer

Test Validated to Predict Recurrence Risk and Radiation Therapy Benefit in Breast Cancer

A blinded validation in more than 400 women shows the test provides clearer guidance on recurrence risk and radiation therapy decisions.

Cancer

Medicare Covers Ultrasensitive MRD Test for Breast Cancer Surveillance

Coverage applies to stage II and III breast cancer patients across three major subtypes for up to six years of recurrence monitoring.

Cancer

New Kitted NGS Panel Launches Targeting Lymphoid Malignancies

Research-use kit interrogates 84 genes using single-tube protocol, compatible with existing molecular laboratory equipment.

Blood Test Shows Superior Sensitivity for Early-Stage Liver Cancer Detection

Nov 7, 2025 | Cancer

Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.

Watchmaker Genomics Launches New Tech Enabling Simultaneous Detection of Methylation and Genetic Variants

Nov 6, 2025 | Cancer

TAPS+ chemistry preserves DNA integrity in challenging samples including FFPE tissue and circulating tumor DNA.

UC San Diego Health Now Offering Blood Test for Testicular Cancer

Nov 5, 2025 | Cancer

The test measures microRNA-371a-3P biomarker and can guide treatment decisions while reducing need for some CT scans during surveillance.

Blood Test Shows High Accuracy for Early Ovarian Cancer Detection

Oct 31, 2025 | Cancer

A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.

Blood Test Shows Promise for Tailoring Colon Cancer Chemotherapy

Oct 30, 2025 | Colorectal

Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.

Breaking Down Barriers to Cervical Cancer Screening Compliance by Introducing Self-Collection

Oct 30, 2025 | Cervical (HPV)

Self-collection for HPV and other infections offers a more convenient, private way to complete recommended screenings—helping reach women who might otherwise delay or skip care.

Study Validating Esophageal Cancer Test Accepted by Gastroenterology Journal

Oct 27, 2025 | Cancer

The mass spectrometry-based assay achieved 100% sensitivity in detecting patients who later progressed to cancer in a blinded cohort study.

Large Melanoma Trial Validates Gene Expression Test’s Predictive Accuracy

Oct 24, 2025 | Melanoma

A study of nearly 1,800 patients shows a threefold difference in sentinel node metastasis rates between high-risk and low-risk groups.

Biodesix Expands Bio-Rad Partnership for Droplet Digital PCR Assay Development

Oct 24, 2025 | Breast

The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.

Multi-Cancer Blood Test Shows Seven-Fold Increase in Detection When Added to Standard Screening

Oct 24, 2025 | Cancer

PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.